FDA 483 - Collaborative Care Diagnostics, LLC dba BioMedix - October 18, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Collaborative Care Diagnostics, LLC dba PCL-Medix in Eagan, MN, revealed two observations concerning inadequate design control procedures for their PADnet 4.0 system. The firm failed to adequately establish and implement procedures for design validation, with specific requirements not being tested. Additionally, procedures for design input were not adequately established, as the product requirement specifications lacked crucial system requirements.
- Inspection Date
- October 18, 2021
- Product Type
- Device
ID · f97c0474-caad-4bcb-b4f2-d913c27a238c